Stryker declares an $0.88 per share quarterly dividend
Stryker (NYSE:SYK) announced a quarterly dividend of $0.88 per share, payable January 30, 2026 to shareholders of record at the close of business on December 31, 2025.
Rhea-AI Summary
Stryker (NYSE:SYK) announced a quarterly dividend of $0.88 per share, payable January 30, 2026 to shareholders of record at the close of business on December 31, 2025. The Board said the payout represents a 4.8% increase versus both the prior year and the previous quarter. Management framed the raise as consistent with the company’s capital allocation priorities and confidence in future financial performance.
Positive
- Dividend set at $0.88 per share
- Payment date: January 30, 2026
- Record date: December 31, 2025
- Declared increase of 4.8% versus prior year and prior quarter
Negative
- None.
Details
News Market Reaction – SYK
On Dec 11, the day this news came out, SYK closed 0.23% below the previous close.
Data tracked by StockTitan Argus for the Dec 11 session.
Key Figures
- Quarterly dividend
- $0.88 per share
- Declared by Board, latest announcement
- Dividend increase
- 4.8%
- Increase vs prior year and previous quarter
- Payment date
- January 30, 2026
- Dividend payable date
- Record date
- December 31, 2025
- Shareholders of record date
Historical Context
-
Named new President and COO emphasizing continuity and internal succession.
-
Reported strong Q3 growth, margin expansion, and raised full-year guidance.
-
Highlighted expanded trauma portfolio and solutions at an industry meeting.
-
Announced timing and webcast details for upcoming Q3 2025 results.
-
Launched FDA-cleared Incompass Total Ankle System at a major meeting.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of
“We remain confident in our ability to deliver strong financial performance, and consistent with our capital allocation priorities we are increasing our dividend to
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.